Literature DB >> 24045385

The role of neutrophyl lymphocyte count ratio as an inflammatory marker in systemic lupus erythematosus.

Amaylia Oehadian1, Hendarsyah Suryadinata, Sumartini Dewi, Riardi Pramudyo, Bachti Alisjahbana.   

Abstract

AIM: to evaluate neutrophyl lymphocyte count ratio (NLCR) as an inflammatory marker in systemic lupus erythematosus (SLE).
METHODS: this was a cross sectional study involving 21 SLE patients with mild and moderate disease activity according to Mex SLEDAI score and 30 normal subjects. White blood cells counts were examined with Sysmex XE-5000. The absolute neutrophyl count and absolute lymphocyte count were tabulated and compared between SLE and normal subjects using unpaired t-test. The comparison of NLCR between SLE and normal subject was calculated using Mann-Whitney test. This study was conducted in the Department of Internal Medicine Hasan Sadikin Hospital from November 2011 until January 2012.
RESULTS: there was no significant difference in absolute neutrophyl count between SLE and normal subjects (4158+1517 vs 4031+1218 /mm3, p=0.74). The absolute lymphocyte count was significantly lower in SLE than normal subjects (1721+600 vs 2397+587/mm3, p=0.000). NLCR was significantly higher in SLE than normal subjects (2.52 (1.01-10.92) vs 1.65 (0.77-4.59), p=0.007). There was no significant difference in NLCR between SLE with mild and moderate activity (2.59 (1.01-10.92) vs 2.01 (1.38-3.98), p= 0.412). Based on ROC curve, with AUC 0.727, cut off NLCR value >1.93 had 70% sensitivity and 67% specificity in differentiating between SLE and normal subjects.
CONCLUSION: NLCR could be used as simple inflammatory parameter in SLE.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24045385

Source DB:  PubMed          Journal:  Acta Med Indones        ISSN: 0125-9326


  8 in total

1.  Can Complete Blood Count Picture Tell Us More About the Activity of Rheumatological Diseases?

Authors:  Sara I Taha; Sara F Samaan; Rehab Ali Ibrahim; Nouran M Moustafa; Eman M El-Sehsah; Mariam K Youssef
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2022-04-22

2.  Relationship between Neutrophil-to-Lymphocyte Ratio and Systemic Lupus Erythematosus: A Meta-analysis.

Authors:  Liping Wang; Chunyan Wang; Xuqiang Jia; Minghui Yang; Jing Yu
Journal:  Clinics (Sao Paulo)       Date:  2020-04-17       Impact factor: 2.365

3.  Correlation of neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and mean platelet volume (MPV) with gout activity: A monocentric and retrospective study.

Authors:  Haihua Wu; Hui Zhou; Panfeng Chen
Journal:  Medicine (Baltimore)       Date:  2022-09-02       Impact factor: 1.817

4.  Hematological Indices May Be Useful in the Diagnosis of Systemic Lupus Erythematosus and in Determining Disease Activity in Behçet's Disease.

Authors:  Servet Yolbas; Ahmet Yildirim; Nevzat Gozel; Burak Uz; Suleyman Serdar Koca
Journal:  Med Princ Pract       Date:  2016-06-24       Impact factor: 1.927

5.  The Relationship between Hematological Indices and Autoimmune Rheumatic Diseases (ARDs), a Meta-Analysis.

Authors:  Xuanyu Hao; Dongyang Li; Dan Wu; Ning Zhang
Journal:  Sci Rep       Date:  2017-09-07       Impact factor: 4.379

6.  Red blood cell distribution width-to-platelet ratio as a disease activity-associated factor in systemic lupus erythematosus.

Authors:  Siyan Xie; Xuejie Chen
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

7.  Neutrophil to Lymphocyte Ratio and Mean Platelet Volume as Inflammatory Indicators in Systemic Lupus Erythematosus Nephritis.

Authors:  Ata Bora Ayna; Selime Ermurat; Belkis Nihan Coşkun; Halil Harman; Yavuz Pehlivan
Journal:  Arch Rheumatol       Date:  2016-08-17       Impact factor: 1.472

8.  Development of Atherosclerotic Cardiovascular Mortality in Gouty Arthritis and Rheumatoid Arthritis Patients: Are They Associated With Mean Platelet Volume and Neutrophil-Lymphocyte Ratio? A Comparative Study.

Authors:  Muhammet Maden; Gülsüm Emel Pamuk; Ömer Nuri Pamuk
Journal:  Arch Rheumatol       Date:  2017-02-01       Impact factor: 1.472

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.